MUTYH and ovarian cancer: Although COSMIC has identified somatic MUTYH mutations in 0.24% (3/1229) of curated ovarian cancers [37], many oncology practices only test ovarian cancer patients with next-generation sequencing for somatic BRCA1/2 mutations or mismatch repair deficiency [51,52], suggesting this rate may be an underestimate.